Maosong Lin

684 total citations
18 papers, 360 citations indexed

About

Maosong Lin is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Maosong Lin has authored 18 papers receiving a total of 360 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cancer Research and 6 papers in Oncology. Recurrent topics in Maosong Lin's work include MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (6 papers) and Cancer-related molecular mechanisms research (6 papers). Maosong Lin is often cited by papers focused on MicroRNA in disease regulation (6 papers), Circular RNAs in diseases (6 papers) and Cancer-related molecular mechanisms research (6 papers). Maosong Lin collaborates with scholars based in China. Maosong Lin's co-authors include Junxing Huang, Hong Yu, Haihui Sheng, Weichang Chen, Hengjun Gao, Yi Sun, Jiayi Zhu, Hongzhang Shen, Hui Chen and Zhenyu Zhang and has published in prestigious journals such as Colloids and Surfaces A Physicochemical and Engineering Aspects, Oncology Reports and Cancer Management and Research.

In The Last Decade

Maosong Lin

17 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maosong Lin China 11 225 209 94 69 49 18 360
Qiliang Peng China 13 268 1.2× 260 1.2× 126 1.3× 43 0.6× 93 1.9× 43 466
De-Bing Shi China 9 264 1.2× 275 1.3× 91 1.0× 46 0.7× 58 1.2× 9 473
Canhui Jin China 13 262 1.2× 334 1.6× 113 1.2× 58 0.8× 54 1.1× 16 494
Ning Ning China 8 266 1.2× 264 1.3× 138 1.5× 33 0.5× 43 0.9× 12 432
Jiahuai Wen China 10 164 0.7× 162 0.8× 161 1.7× 58 0.8× 67 1.4× 17 380
Mauricio Camus Chile 13 187 0.8× 211 1.0× 143 1.5× 79 1.1× 32 0.7× 49 487
Haizhou Guo China 12 212 0.9× 259 1.2× 52 0.6× 70 1.0× 55 1.1× 21 379
Satoru Inoguchi Japan 10 410 1.8× 461 2.2× 45 0.5× 55 0.8× 68 1.4× 21 567
Grażyna Drabik Poland 14 117 0.5× 134 0.6× 134 1.4× 62 0.9× 100 2.0× 28 361
Silvia Cruz-Gil Spain 6 212 0.9× 225 1.1× 55 0.6× 19 0.3× 51 1.0× 9 331

Countries citing papers authored by Maosong Lin

Since Specialization
Citations

This map shows the geographic impact of Maosong Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maosong Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maosong Lin more than expected).

Fields of papers citing papers by Maosong Lin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maosong Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maosong Lin. The network helps show where Maosong Lin may publish in the future.

Co-authorship network of co-authors of Maosong Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Maosong Lin. A scholar is included among the top collaborators of Maosong Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maosong Lin. Maosong Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lin, Maosong, et al.. (2025). pH-responsive guar gum-based hydrogels for controlled release and antifungal applications of carvacrol. Colloids and Surfaces A Physicochemical and Engineering Aspects. 728. 138594–138594.
2.
Lin, Maosong, et al.. (2019). <p>MicroRNA-193a-3p suppresses the colorectal cancer cell proliferation and progression through downregulating the PLAU expression</p>. Cancer Management and Research. Volume 11. 5353–5363. 54 indexed citations
3.
Sun, Yi, Bin Yang, Maosong Lin, et al.. (2019). Identification of serum miR-30a-5p as a diagnostic and prognostic biomarker in colorectal cancer. Cancer Biomarkers. 24(3). 299–305. 38 indexed citations
4.
Lin, Maosong, Bensong Duan, Jiangfeng Hu, et al.. (2017). Decreased expression of miR-193a-3p is associated with poor prognosis in colorectal cancer. Oncology Letters. 14(1). 1061–1067. 24 indexed citations
5.
Lin, Maosong, et al.. (2017). Prognostic significance of preoperative platelet-lymphocyte ratio in a Chinese cohort patient with colorectal cancer.. PubMed. 10(8). 8686–8694. 4 indexed citations
6.
Lin, Maosong, Yiwei Fu, Hong Yu, & Junxing Huang. (2015). Gastric heterotopic pancreas masquerading as a stromal tumor: A case report. Oncology Letters. 10(4). 2355–2358. 5 indexed citations
7.
Huang, Junxing, Juan Yao, Maosong Lin, et al.. (2015). Evaluation of tumor metastasis-associated markers for molecular classification in patients with esophageal squamous cell carcinoma.. PubMed. 8(9). 15920–9. 1 indexed citations
8.
Lin, Maosong, Junxing Huang, & Hong Yu. (2015). Prognostic significance of Glasgow prognostic score in patients with stage II colorectal cancer.. PubMed. 8(10). 19138–43. 12 indexed citations
9.
Lin, Maosong, Weichang Chen, Junxing Huang, Hengjun Gao, & Haihui Sheng. (2014). Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer.. PubMed. 7(12). 5226–34. 50 indexed citations
10.
Lin, Maosong, Junxing Huang, & Hong Yu. (2014). Elevated serum level of carbohydrate antigen 19-9 in benign biliary stricture diseases can reduce its value as a tumor marker.. PubMed. 7(3). 744–50. 33 indexed citations
11.
Zhao, Kun, Mei Lin, Qi Wang, et al.. (2013). HER2 gene amplification in esophageal squamous cell carcinoma is less than in gastroesophageal junction and gastric adenocarcinoma. Oncology Letters. 6(1). 13–18. 14 indexed citations
12.
Lin, Maosong, Junxing Huang, Jiayi Zhu, & Hongzhang Shen. (2013). Elevated pre-treatment levels of high sensitivity C-reactive protein as a potential prognosticator in patients with colorectal cancer. Experimental and Therapeutic Medicine. 6(6). 1369–1374. 17 indexed citations
13.
Lin, Mei, Wei Xiao, Weichang Chen, et al.. (2012). Cyclin A overexpression is associated with chemosensitivity to paclitaxel-based chemotherapy in patients with esophageal squamous cell carcinoma. Oncology Letters. 4(4). 607–611. 7 indexed citations
14.
Lin, Maosong, Jiayi Zhu, Hongzhang Shen, & Junxing Huang. (2012). Gastrointestinal bleeding as an initial manifestation in asymptomatic multiple myeloma: A case report and review of the literature. Oncology Letters. 5(1). 218–220. 8 indexed citations
15.
Huang, Junxing, Wei Xiao, Weichang Chen, et al.. (2010). Relationship between COX-2 and cell cycle-regulatory proteins in patients with esophageal squamous cell carcinoma.. PubMed. 16(47). 5975–81. 12 indexed citations
16.
Chen, Weichang, et al.. (2010). Clinical significance of aberrant microRNAs expression in human colorectal cancer. World Chinese Journal of Digestology. 18(30). 3187–3187. 2 indexed citations
17.
Lin, Maosong. (2010). MicroRNA expression profiles in human colorectal cancers with liver metastases. Oncology Reports. 25(3). 739–47. 64 indexed citations
18.
Chen, Weichang, Maosong Lin, & Xia Bai. (2005). Induction of apoptosis in colorectal cancer cells by peroxisome proliferators-activated receptor gamma activation up-regulating PTEN and inhibiting PI3K activity.. PubMed. 118(17). 1477–81. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026